0RGT

Demant A/S

Stock London Stock Exchange – Stock Market Prices, News & Analysis

Demant is a global provider of hearing solutions, developing and marketing hearing aids, diagnostic equipment, and hearing healthcare services.

£ 2.76
42.50 %

Demant A/S

£ 2.76
42.50 %
0RGT

Demant is a global provider of hearing solutions, developing and marketing hearing aids, diagnostic equipment, and hearing healthcare services.

Price history of Demant A/S
Price history of Demant A/S

Performance & Momentum

6 Months 15.12 %
1 Year 13.74 %
3 Years 19.04 %
5 Years 32.57 %

Strategic Analysis

Demant A/S • 2026

Demant A/S positions itself as a global player specialized in hearing solutions, combining technological innovation and expertise in hearing diagnostics to meet the growing needs of auditory health. Its business model relies on an integrated offering of hearing aids and associated services, which provides a level of resilience in a changing market.

Strengths
  • Leadership in hearing medical with strong expertise in innovation
  • Diversified portfolio including hearing aids, diagnostic equipment, and services
  • Niche positioning in a structurally growing auditory health market
Weaknesses
  • Deteriorated stock performance in recent years, affecting investor confidence
  • Vulnerability to pricing pressures and increased competition in the medical technology sector
Momentum

Demant's momentum reflects a persistent downward trend, indicating a challenging market context and internal challenges to overcome. The lack of recent catalysts and past underperformance calls for caution, although its underlying technological positioning remains a potential lever for medium-term recovery.

Similar stocks to Demant A/S

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone